Expression profiling using cDNA microarrays have redefined the molecular classification of some cancers. The comprehensive genetic analysis also permits the identification of novel pathways that might determine subtle differences in tumor phenotype. Herein, we analyzed the tissues from a patient with bilateral cancer of different histologies in each breast (pure invasive mucinous and pure invasive ductal), thus providing a unique opportunity to assess the expression profiles determined by histology in an isogenic human background. Our results show that the mucinous phenotype is associated with the expression of immunostimulatory and inhibitory genes, consistent with the cellular infiltration of lymphocytes and with the expression of enzymes...
Progression of invasive carcinoma involves the deregulation of molecular signaling pathways that res...
International audienceBreast cancer is the most frequent and deadly cancer of women. Its great heter...
Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopath...
OBJECTIVE: The purpose of this study was to investigate the expression of MUC1, MUC2, MUC5AC and MUC...
Breast cancer develops through multiple stages from hyperplasia to invasive and finally metastatic d...
Comparative and functional genomics are powerful tools to advance the understanding of the molecular...
Metaplastic carcinoma of the breast (MCB) is a poorly understood subtype of breast cancer. It is gen...
Mucinous carcinomas can arise in any organ with epithelial cells that produce mucus. While mucinous ...
[[abstract]]Metaplastic carcinoma of the breast (MCB) is a poorly understood subtype of breast cance...
Breast cancer is one of the leading causes of death from cancer among women in western countries. Th...
AbstractHere we describe the comprehensive gene expression profiles of each cell type composing norm...
Background Gene expression profiling has been used to define molecular phenotypes of...
The most integrated approach toward understanding the multiple molecular events and mechanisms by wh...
International audienceMedullary breast cancer (MBC) is a rare but enigmatic pathologic type of breas...
Breast cancer is a very heterogeneous disease. This heterogeneity can be observed at many levels, in...
Progression of invasive carcinoma involves the deregulation of molecular signaling pathways that res...
International audienceBreast cancer is the most frequent and deadly cancer of women. Its great heter...
Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopath...
OBJECTIVE: The purpose of this study was to investigate the expression of MUC1, MUC2, MUC5AC and MUC...
Breast cancer develops through multiple stages from hyperplasia to invasive and finally metastatic d...
Comparative and functional genomics are powerful tools to advance the understanding of the molecular...
Metaplastic carcinoma of the breast (MCB) is a poorly understood subtype of breast cancer. It is gen...
Mucinous carcinomas can arise in any organ with epithelial cells that produce mucus. While mucinous ...
[[abstract]]Metaplastic carcinoma of the breast (MCB) is a poorly understood subtype of breast cance...
Breast cancer is one of the leading causes of death from cancer among women in western countries. Th...
AbstractHere we describe the comprehensive gene expression profiles of each cell type composing norm...
Background Gene expression profiling has been used to define molecular phenotypes of...
The most integrated approach toward understanding the multiple molecular events and mechanisms by wh...
International audienceMedullary breast cancer (MBC) is a rare but enigmatic pathologic type of breas...
Breast cancer is a very heterogeneous disease. This heterogeneity can be observed at many levels, in...
Progression of invasive carcinoma involves the deregulation of molecular signaling pathways that res...
International audienceBreast cancer is the most frequent and deadly cancer of women. Its great heter...
Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopath...